A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.
about
Adenovirus vectors for gene therapy, vaccination and cancer gene therapyOncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF.Future directions and treatment strategies for head and neck squamous cell carcinomasBiodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues.Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activationOncolytic adenoviruses expressing interleukin: a novel antitumour approach.New perspectives in cancer virotherapy: bringing the immune system into play.Use of attenuated paramyxoviruses for cancer therapy.Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers.Evolution of oncolytic viruses: novel strategies for cancer treatment.Viral gene therapy for head and neck cancer.Oncolytic viruses: a new class of immunotherapy drugs.Gene therapy research in Asia.Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy.Oncolytic virotherapy for head and neck cancer: current research and future developments.Novel oncolytic viral therapies in patients with thoracic malignancies.Oncolytic immunotherapy: unlocking the potential of viruses to help target cancerChemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs.Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.[YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?].Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.CD20-targeted measles virus shows high oncolytic specificity in clinical samples from lymphoma patients independent of prior rituximab therapy.The current status of oncolytic viral therapy for head and neck cancer.
P2860
Q27001601-09DC3864-3E6C-43A5-AE22-F1B26071478DQ33906116-B21B7EA3-14DD-4163-BB06-EA77D64C804FQ33924515-A10A59E9-D893-400B-B7B0-1292BA88ECB0Q34183436-2F62C0FE-36A9-449F-AACF-0A827E3401C3Q36177257-1ABBA368-FA8E-4B6A-9027-62D629501D50Q36757131-09711069-D7BE-46C9-8FB5-72920F4B5B4BQ37716633-102782B1-7FAA-4213-BE72-62DDEA962175Q37733550-218C9CD1-C0C0-4DF1-A289-2032B1F399E2Q37773253-6C8313F9-2607-4456-9CA1-BBA26FB7F09BQ37810599-D7EA23BD-367F-47AB-8475-A97646D75612Q38073096-7B0758C7-7B5A-4D66-A77A-5E77C9874AC0Q38159802-59D2035C-93E8-4744-B443-AE554D807EC3Q38381706-52D2BC4B-5CB0-4D9B-9B25-765BD536767DQ38577450-F1C7D408-A76D-4DA1-B800-FB5518C8A3A7Q38654544-9A9551BD-8EF6-48A9-9E0A-9A098E513519Q38924557-23F91AE0-4CD0-4E8C-9353-FE3137832C80Q38924562-93B6E958-7741-46D2-A6F4-FD77E5538549Q39067827-BC64584F-59B2-4DEB-B5A8-DCBCE617A211Q39437344-02270584-936D-48BC-9C7D-92A6C1BF5216Q39444656-A5B8AFBB-D045-42D6-9038-10040656674CQ39491372-BBA28704-E017-4E2F-BD42-6FE994A84C12Q39532576-FE1F825D-6370-479A-AFB5-226812499DFFQ41133867-C5A9A44D-34B9-424A-B787-370C8535B19DQ41684403-B0026A33-2DF6-433B-96D2-4DF2F17040B3Q41880131-080396BD-68AC-43C0-952E-AFF5CCC46BD5Q52859083-D4912534-80E0-46A0-9FBA-7F8A8E38B33C
P2860
A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A Phase I study of KH901, a co ...... ment of head and neck cancers.
@en
A Phase I study of KH901, a co ...... ment of head and neck cancers.
@nl
type
label
A Phase I study of KH901, a co ...... ment of head and neck cancers.
@en
A Phase I study of KH901, a co ...... ment of head and neck cancers.
@nl
prefLabel
A Phase I study of KH901, a co ...... ment of head and neck cancers.
@en
A Phase I study of KH901, a co ...... ment of head and neck cancers.
@nl
P2093
P356
P1476
A Phase I study of KH901, a co ...... ment of head and neck cancers.
@en
P2093
Jianhua Chang
Junnin Cao
Xianghua Wu
Xiaoying Zhao
P304
P356
10.4161/CBT.8.8.7913
P577
2009-04-22T00:00:00Z